Exodus Point Capital Management, LP Unity Biotechnology, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.4 - $4.27 $203,956 - $2.18 Million	509,892 New	509,892 $201,000
Q1 2022 May 13, 2022	SELL	$0.72 - $1.86 $34,462 - $89,028	-47,865 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.3 - $3.17 $42,428 - $103,459	32,637 Added 214.32%	47,865 $70,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.5 $65,937 - $101,965	-22,659 Reduced 59.81%	15,228 $46,000
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $60,469 - $91,797	14,571 Added 62.49%	37,887 $176,000
Q1 2021 May 17, 2021	BUY	$5.51 - $9.42 $16,254 - $27,789	2,950 Added 14.48%	23,316 $140,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $69,651 - $129,527	20,366 New	20,366 $107,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14.5M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.